US Edition
Elephants don’t gallop – except for AstraZeneca
Questor share tip: the company’s growth rate and valuation suggest further capital gains are ahead
Advertisement
-
Why your life is worth less to the NHS than 20 years ago
Health service is willing to pay half as much on new drugs to give you ‘perfect health’
-
Shortage of weight-loss drug Wegovy will last for years
Sales of Novo Nordisk's obesity treatments grew 36pc in the first nine months of the year
-
Jail for Indonesian drug manufacturers over cough syrup linked to 200 child deaths
Company’s chief executive and three other senior employees given two-year prison sentences and fined £52,000
-
After a tenfold gain on a drugs maker, here is that investor’s next choice
Questor share tip: The Swiss pharmaceutical company appears to offer the same potential that Eli Lilly did before its 987pc gain
-
Boots is just the latest disastrous foreign takeover of a British retailer
Our high streets are littered with proof that running a chain from thousands of miles away doesn’t work
-
AstraZeneca pays £350m to settle heartburn drugs lawsuits
Pharmaceutical giant agrees to pay claimants but does not admit any wrongdoing
-
Nasal spray to rival EpiPen delayed over efficacy concerns
There had been high hopes for a new product which aims to replace the one-time-use adrenaline shots with an easy to use nasal spray
-
What a pharmacist can treat – and when to go to your GP
Pharmacists are highly qualified and could be the quick-fix solution you need for your ailment. Here’s what they can do
-
ChatGPT pioneer launches ‘biological software’ company
Start-up raises £80m from investors amid plans to use generative AI to invent new drugs
-
This stock is in the last chance saloon – it needs to start delivering now
Questor share tip: If Smith & Nephew can't follow through on its plan to cut costs and increase margins the shares are dead money at best
-
The ‘miracle’ weight loss drug causing euphoria and fear in Scandinavia
A sudden rush of demand for Wegovy has been met with mixed reactions in Denmark
Advertisement
-
Britain’s trade deal with India at risk amid row over cheap generic drugs
Negotiators reject UK demands for patents to protect pharmaceutical giants
-
Slimfast suffers as dieters turn to Ozempic
Diet supplement company sees sales drop as demand for blockbuster drugs surges
-
The Ozempic-killers already delivering fat profits
A booming weight loss drug market has investors scrambling for a slice of the action
-
Bogus British company caught selling toxic cough syrup in Cameroon
The WHO says a remedy sold under the brand name Naturcold had more than 200 times the acceptable amount of the solvent diethylene glycol
-
NHS ranks as one of the worst health systems among major nations
King’s Fund study finds UK is worst at saving stroke victims while ‘underperforming significantly’ on cancer and life expectancy
-
Indian authorities investigate bribe claims surrounding ‘switched samples’ of lethal cough syrup
Officials launch inquiry into an allegation that a state drug controller was paid £480,000
-
India recalls typhoid vaccine as quality concerns persist over its pharma industry
The latest incident raises further questions about the sector’s credibility and the effectiveness of its regulatory systems
-
Pharma chiefs warn red tape and NHS levy risk Britain missing out on billions
Industry leader says policy shake up is needed to incentivise big pharma to build factories
-
Blood cancer drug offers rare hope to sufferers, study finds
Cilta-cel, which is not available in UK because of a row with NICE, has been shown to stop spread of incurable condition
-
My seven point plan to free GPs from the tyranny of NHS managers
They’re hugely valuable, but pharmacists aren’t doctors – we need to decrease GPs’ insane workload
-
Public will be told to use their GP wisely as NHS says one in seven appointments needless
The £645m plan to ease pressure on family doctors as Government already admits it will miss its recruitment targets
